Liraglutide mitigates TNF-α induced pro-atherogenic changes and microvesicle release in HUVEC from diabetic women. [electronic resource]
Producer: 20180627ISSN:- 1520-7560
- Atherosclerosis -- drug therapy
- Female
- Human Umbilical Vein Endothelial Cells -- drug effects
- Humans
- Hypoglycemic Agents -- pharmacology
- Intercellular Adhesion Molecule-1 -- metabolism
- Liraglutide -- pharmacology
- Oxidative Stress -- drug effects
- Tumor Necrosis Factor-alpha -- pharmacology
- Vascular Cell Adhesion Molecule-1 -- metabolism
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.